Current barriers to treatment for wet age-related macular degeneration (wAMD): findings from the wAMD patient and caregiver survey
Monica Varano,1 Nicole Eter,2 Steve Winyard,3 Kim U Wittrup-Jensen,4 Rafael Navarro,5 Julie Heraghty6On behalf of the wAMD Patient and Caregiver Survey Committee members1Department of Ophthalmology, Fondazione GB Bietti-IRCCS, Rome, Italy; 2Department of Ophthalmology, University of Münster...
Guardado en:
Autores principales: | Varano M, Eter N, Winyard S, Wittrup-Jensen KU, Navarro R, Heraghty J |
---|---|
Formato: | article |
Lenguaje: | EN |
Publicado: |
Dove Medical Press
2015
|
Materias: | |
Acceso en línea: | https://doaj.org/article/dbb8d06aa46e4226b36e810d3a8ced42 |
Etiquetas: |
Agregar Etiqueta
Sin Etiquetas, Sea el primero en etiquetar este registro!
|
Ejemplares similares
-
The emotional and physical impact of wet age-related macular degeneration: findings from the wAMD Patient and Caregiver Survey
por: Varano M, et al.
Publicado: (2016) -
Epimacular brachytherapy for wet AMD: current perspectives
por: Casaroli-Marano RP, et al.
Publicado: (2014) -
Initial non-responders to ranibizumab in the treatment of age-related macular degeneration (AMD)
por: Otsuji T, et al.
Publicado: (2013) -
Spatio-temporal alterations in retinal and choroidal layers in the progression of age-related macular degeneration (AMD) in optical coherence tomography
por: Wolf-Dieter Vogl, et al.
Publicado: (2021) -
Real-World Visual And Clinical Outcomes For Patients With Neovascular Age-Related Macular Degeneration Treated With Intravitreal Ranibizumab: An 8-Year Observational Cohort (AMD8)
por: Horner F, et al.
Publicado: (2019)